Refine by
Healthcare Research Articles & Analysis
131 news found
By making BC Mosaic available through AWS Marketplace and combining federated architecture, AI-native workflows, NVIDIA tools, and governance built for today’s regulatory landscape, we’re giving life sciences and healthcare organizations a practical, cost effective, and scalable foundation for collaborative research,” said Keith Collier, Chief Product Officer, BC ...
In this free webinar, learn about the importance of early glycan screening for ensuring biologic quality, and how automation reduces time-to-insight and improves workflow efficiency. The featured speakers will share real-world applications and results from glycan screening success. Attendees will learn how to integrate automated glycan profiling into cell line development (CLD) labs. Early ...
As antibiotic resistance continues to pose a global health threat, Profacgen is expanding its services to assist researchers, pharmaceutical companies, and healthcare providers in developing new antimicrobial agents that could shape the future of infectious disease treatment. ...
"We are confident that Semaglutide will have a significant impact on the lives of patients, helping them achieve better glycemic control, weight management, and overall health outcomes," said the senior scientist. "We invite healthcare professionals, researchers, and industry partners to explore the remarkable potential of this innovative peptide and discover how ...
Acinetobacter is described by the Centers for Disease Control and Prevention (CDC) as a group of bacteria commonly found in the environment. While there are many types, the most frequent cause of infections in humans is Acinetobacter baumannii. Infections of the blood, urinary tract, and lungs, or in wounds in other parts of the body can all be caused by Acinetobacter baumannii. It can also ...
CD Formulation's antiserum preparation services cater to a myriad of research and healthcare needs. Their offerings include specialized services in antiviral serum, antibacterial serum, and antitoxin serum preparation. ...
This webinar focuses on the different types of quality control (QC) required for iPSCs, with an emphasis on the International Society for Stem Cell Research (ISSCR) standards guidance. Genomic stability assessment is a crucial part of QC since up to 30 percent of cultures have genomic or genetic changes that can affect downstream usage with significant implications for cell-based ...
Prophecy Market Research says it could reach US$ 508.7 billion by 2034. From data to diagnostics and imaging, drug development and discovery, early intervention and predictive analytics, remote patient monitoring and robotics, AI is revolutionizing healthcare as we know it. Betting on healthcare as a key market, Avant Technologies, Inc. (OTCQB: ...
Join this webinar to investigate the effects of simultaneously adjusting temperature and osmolality on the generation of HCPs, antibody yield and cell growth. Join Syazana Mohamad Pauzi, Research Scientist, Imperial College of London, for the live webinar on Thursday, February 8, 2024, at 11am EST (4pm GMT/UK). ...
Laboratory scientists across the world are being invited to have their say in the 2024 Scientists’ Choice Awards®. The annual Scientists’ Choice Awards celebrate the most innovative and effective technologies of the past year and provide scientists worldwide with the opportunity to acknowledge the instruments, assays, tools, or consumables that have made the most difference to ...
The focus industries include healthcare & biomedical sciences, smart cities & urban solutions, trade & connectivity, and emerging sustainable technologies. ...
In vitro diagnostics (IVD) are tests done on samples such as blood or tissue for the purpose of detecting diseases or other conditions. To facilitate efforts on IVD research, the US-based chemical supplier Alfa Chemistry has recently introduced three IVD products for laboratory use, adding to its already diverse range of biological reagents. ...
Harnessing molecular dynamics simulations, advanced structural bioinformatics, and artificial intelligence, the company accelerates the drug discovery journey. This empowers researchers and pharmaceutical entities to tailor antibody therapies for an extensive array of diseases, ranging from cancer to autoimmune disorders. ...
CD ComputaBio is committed to collaborating with pharmaceutical companies, research institutions, and healthcare providers to advance the field of antibody-based therapies and Protein Drug Design further. ...
With its potent bactericidal activity against Gram-positive pathogens, Daptomycin has been a crucial treatment option for healthcare professionals around the world. Daptomycin ReadyMade™ Solution is a sterile filtered solution prepared in a 10% β-cyclodextrin saline solution with a concentration of 1mg/ml. ...
Neeka is led by a team of proven healthcare and clinical research innovators and is taking a disruptive approach to healthcare by encompassing a holistic approach to improving the quality of life for struggling and transition populations by using the proprietary Neeka peer support platform coupled with science based natural therapeutics. ...
About SeqOne Genomics SeqOne Genomics specializes in high-performance genomic analysis solutions for use in healthcare and life science – hospitals, research institutions, and pharmaceutical companies. ...
Earlier this month, CD Formulation announced it has launched a wide portfolio of natural, functional, and synthetic food ingredients for both researchers and manufacturers of healthcare products. Over the past decades, numerous ingredients have performed a variety of useful functions in many types of foods. ...
Lumosa's Chief Business Officer, Mr. Christopher Aleong will be serving as one of the judges in the Innovator's Pitch Challenge at the RESI (Redefining Early Stage Investments) Conference, on September 21~22, 2022. The Innovator’s Pitch Challenge (IPC) is an opportunity for early-stage life science and healthcare companies to gain additional exposure to conference attendees and pitch ...
“This transforms the nature and scope of our understanding of patient outcomes and is critical to rapidly advancing research and care.” Other partners joining xCures in building this relationship with Aetion include AbbVie, Amgen, AstraZeneca, Bayer, Baylor College of Medicine, Brigham and Women’s Hospital and Harvard Medical School, ConcertAI, Duke-Margolis ...
ByxCures